Overview
Lobbying Costs
None declared
Financial year: Jan 2013 - Dec 2013
Lobbyists (Full time equivalent)
None declared
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
European AIDS Treatment Group (EATG)
EU Transparency Register
49959188061-85 First registered on 13 Feb 2012
Goals / Remit
Founded in 1992, the European AIDS Treatment Group (EATG) is a European network of nationally-based activists. As a European patient-led advocacy organisation, it has been at the forefront of the development of the civil society response to the HIV/AIDS epidemic in Europe. It represents and defends the treatment-related interests of people living with HIV and AIDS.
EATG is a voluntary organisation made up of over 100 members from over 35 different European countries. Our members are representatives of different communities affected by HIV/AIDS in Europe. Our activities focus on treatment activism and treatment advocacy.
In responding to HIV, the EATG also considers diseases frequently seen as co-infection in people with HIV, as well as other health issues that increase the risk of HIV.
The EATG’s primary geographic focus is the member states served by the World Health Organisation (WHO) Regional Office for Europe. However, the EATG does consider opportunities to collaborate with and support similar efforts in other parts of the world.
goals
1. To enable people with HIV or at risk of HIV infection and their supporters to significantly influence the development, testing and approving of HIV treatments. In this context, HIV treatment means medical devices, products and diagnostic tests that prevent or treat HIV infection and include continuous improvement in the quality of life of people affected.
2. To advocate for the best practices of care and treatment.
3. To advocate for rapidly available existing and new HIV treatment.
4. To promote the access of the latest available information about treatment legislation for patients, health care providers as well as policy makers.
5. To influence changes in legislation and patent law in order to support the lowest achievable cost for HIV treatment, including the support for generic medicine.
6. To monitor the changes in Health care systems and policies to ensure the rights and the quality of services influence positively the quality of life of people living with HIV/AIDS.Main EU files targeted
Address
Head Office
Mettmanner Strasse, 24-26
Duesseldorf 40233
GERMANY -
People
Total lobbyists declared
None declared
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 05 Feb 2015
Name Start date End Date Chiara LONGHI 14 Mar 2024 13 Mar 2025 Ann Isabelle von Lingen 23 Mar 2024 02 Oct 2024 Mr Pieter VANHOLDER 15 May 2020 01 Jun 2021 Ann Isabelle von Lingen 13 May 2020 13 May 2021 Mr Pierre VARASI 20 Feb 2020 20 Feb 2021 Ms Marina COGNEE 20 Feb 2020 20 Feb 2021 Mr Bojan CIGAN 20 Feb 2020 20 Feb 2021 Giorgio BARBARESCHI 20 Feb 2020 20 Feb 2021 Mr Pieter VANHOLDER 18 Apr 2019 01 May 2020 Ann Isabelle von Lingen 04 Apr 2019 04 Apr 2020 Ms Fiona GREENHALGH 04 Apr 2019 12 Feb 2020 Ann Isabelle von Lingen 21 Feb 2017 17 Feb 2018 Complementary Information
None declared
Person in charge of EU relations
None declared
Person with legal responsibility
Mr Koen Block (Executive Director)
-
Categories
Category
III - Non-governmental organisations
Subcategory
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2013 - Dec 2013
Lobbying costs for closed financial year
None declared
EU grant income for closed financial year
84,290 € (Source: FP7)
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
None declared
Communication activities
None declared
Other activities
None declared
- Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 22 Jul 2019 Location Brussels Subject Access to medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
- Arunas Vinciunas (Cabinet member)
Other Lobbyists -
Date 28 Nov 2016 Location Brussels Subject EU and NGOs action on HIV, TB and Hepatitis Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Paula Duarte Gaspar (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
Other Lobbyists
- Meetings